🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The overall aim of the trial is to evaluate the safety, tolerability, and p...
Status
Recruiting
Location
City of Hope National Medical Center
Start Date
2020-03-04
Trial ID
NCT04221542
Treatments Being Tested
This study is to evaluate the safety, and preliminary antitumor activity of...
Status
Not Yet Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2025-08
Trial ID
NCT07104617
The purpose of this study is to provide access to abiraterone acetate for p...
Status
Completed
Location
Multiple Locations
Start Date
2007-04
Trial ID
NCT01664728
Treatments Being Tested
The purpose of this study is to evaluate the safety, pharmacokinetics, phar...
Status
Completed
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00473746
Treatments Being Tested
Primary Objectives: * To determine the maximum tolerated dose, and dose li...
Status
Completed
Location
Investigational Site Number 840001
Start Date
2012-03
Trial ID
NCT01511536
Treatments Being Tested
This first-in-human, Phase 1/2, open-label study evaluates the safety, tole...
Status
Active Not Recruiting
Location
City of Hope National Medical
Start Date
2021-09-02
Trial ID
NCT05067140
Background: * Advanced prostate cancer is treated with surgery or drugs th...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2012-02-08
Trial ID
NCT01553188
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose and ev...
Status
Completed
Location
Multiple Locations
Start Date
2005-11
Trial ID
NCT00473512
Treatments Being Tested
There will be two parts to this clinical research study. The purpose of eac...
Status
Terminated
Location
University of California, San Francisco
Start Date
2013-01-31
Trial ID
NCT01717898
Treatments Being Tested